Phillyrin T2854
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Phillyrin is a novel AMPK activator, has anti-obesity effects in nutritive obesity mice, it can prevent lipid accumulation in HepG2 cells by blocking the expression of SREBP-1c and FAS through LKB1/AMPK activation. Phillyrin may be a new preventive agent
CAS nr:
487-41-2
Purity:
98%
Molecular Weight:
534,56
SMILES:
[C@@H]1([C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)Oc1c(cc(cc1)[C@H]1OC[C@H]2[C@@H]1CO[C@H]2c1cc(c(cc1)OC)OC)OC
Formula:
C27H34O11
Pathway:
PI3K/Akt/mTOR signaling,Metabolism,Microbiology/Virology
Target:
AMPK,P450,Influenza Virus
